University of St.Gallen
research platform alexandria
search publications
browse publications
by person
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
by year

Bleak Prospects for Research in GMP in Switzerland

abstract Many European countries, including Switzerland, share deep suspicions about the broad commercial application of Genetically Modified Plants (GMP) in agriculture. Research in GMP, however, is mostly welcome. In Switzerland, nevertheless, an overprotective legal framework against risks of GMP results in regulatory spillovers for research. This article explores how such expanded legal protection in combination with the application of a strong precautionary principle hampers freedom of research in the field of green gene technology. The authors do not seek, on this occasion, to question the general risk assessment of Swiss legislators and their desire for a high level of protection. However, field trials with GMP will cease to take place if the procedural burdens for researchers are not reduced. In particular, it will be vital to establish research zones (“protected sites”) if research in GMP is to continue to take place in Switzerland.
   
type journal paper
   
keywords
   
project Unternehmen - Recht, Innovation und Risiko
language English
kind of paper journal article
date of appearance 11-2012
journal European Journal of Risk Regulation EJRR
publisher Lexxion Verlag (Berlin)
ISSN 1867-299X
volume of journal 2012
number of issue 03
page(s) 361-371
review double-blind review
   
profile area LS - Business Enterprise - Law, Innovation and Risk
citation Hettich, P., & Walther, S. (2012). Bleak Prospects for Research in GMP in Switzerland. European Journal of Risk Regulation EJRR, 2012(03), 361-371.